Filing Details
- Accession Number:
- 0001615774-16-006118
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2016-06-29 10:20:40
- Reporting Period:
- 2016-06-21
- Filing Date:
- 2016-06-29
- Accepted Time:
- 2016-06-29 10:20:40
- Original Submission Date:
- 2016-06-21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1430306 | Tonix Pharmaceuticals Holding Corp. | TNXP | () | 4/A |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1365615 | R Samuel Saks | C/O Tonix Pharmaceuticals Holding Corp. 509 Madison Avenue, Suite 306 New York NY 10022 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value | Acquisiton | 2016-06-21 | 12,500 | $2.00 | 51,050 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
